Does statin use decrease the amount of Alzheimer disease pathology in the brain?

Neurology

Volumn 69, Issue 9, 2007, Pages

  Silbert, Lisa C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ALZHEIMER DISEASE; DEMENTIA; DISEASE COURSE; DRUG MECHANISM; HUMAN; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SCREENING TEST; SHORT SURVEY;

EID: 34548285912     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000280585.95661.1b     Document Type: Article

References (4)

1. Li G, Larson EB, Sonnen JA, et al. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 2007;69:878-885
2. Fletcher GF, Bufalino V, Costa F, et al. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Am J Cardiol 2007;99:1E-35E.
3. Alzheimer's Association. Alzheimer's disease facts and figures - statistical abstract of U.S. data on Alzheimer's disease. www.alz.org [online]. Available at: www.alz.org/national/documents/Report_2007FactsAndFigures.pdf. Accessed June 15, 2007.
4. Sjogren M, Mielke M, Gustafson D, Zandi P, Skoog I. Cholesterol and Alzheimer's disease - is there a relation? Mech Ageing Dev 2006;127:138-147.